Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
17 October 2024 | Story Anthony Mthembu | Photo Supplied
Prof Tameshnie Deane
Prof Tameshnie Deane, Vice-Dean: Research, Postgraduate Studies and Internationalisation in the Faculty of Law at the University of the Free State (UFS).

The Faculty of Law at the University of the Free State (UFS) has appointed Prof Tameshnie Deane as Vice-Dean: Research, Postgraduate Studies and Internationalisation. Prof Deane officially assumed this role on 1 July 2024, following over two decades as a Professor and Head of the Criminal Law Unit at the University of South Africa (UNISA).

Prof Deane, who has approached this new position with great enthusiasm, describes it as a significant opportunity. ‘’This role allows me to influence the future of academic research and postgraduate education at UFS,’’ she said.

Support for postgraduate students

Prof Deane elaborated on her vision, saying, “My aim is to develop and implement strategies that elevate the quality and impact of research, foster innovation, and support postgraduate students in achieving their academic and professional goals.”

Among her top priorities is strengthening support for postgraduate students at the UFS. “I plan to introduce comprehensive mentorship programmes where experienced faculty members guide students through their academic and research journeys. We will offer training in key skills such as legal writing, research methodologies, and public speaking, while also prioritising initiatives to support their mental and emotional well-being,’’ she explained.

Prof Deane emphasised that creating a dynamic and supportive environment will contribute to academic excellence and personal growth for postgraduate students at the UFS.

Enhancing internationalisation and strategic collaborations

Prof Deane is also committed to advancing the internationalisation of the Faculty of Law.  “We aim to provide opportunities for international collaboration and exchange, which will broaden the scope and impact of our research and postgraduate programmes,’’ she said.

Improving research quality and output remains a core objective, with Prof Deane identifying this as central to her new role.

One of the initiatives Prof Deane is eager to lead is the development of strategic partnerships with industry and academic institutions. “Collaborations like these will provide invaluable resources for research projects,” she noted.

To foster these partnerships, Prof Deane plans to leverage technology to strengthen communication and collaboration, support relationship-building events, and promote interdisciplinary projects that encourage diverse perspectives and innovative solutions. 

News Archive

DNA sequencer launched at the UFS
2013-11-25

Dr Gansen Pillay, Deputy Chief Executive Officer of the National Research Foundation, explaining to the scholars what will be expected of them.

The University of the Free State (UFS) can now collect immensely valuable data on drug resistance in HIV/Aids and TB with the new DNA sequencer that was launched recently at the International workshop on HIV/AIDS and TB drug resistance at the Bloemfontein Campus.

The DNA sequencer will allow the Free State province to produce viral and bacterial genetic data to fight the local development of HIV/ Aids and TB drug resistance.

The HIV and TB epidemics have expanded very fast and South Africa now has the largest HIV and TB treatment programme in the world, with over 2 million patients on treatment. However, these successful treatment programmes are now being threatened by the appearance of drug resistance.

The Free State province has been at the forefront of fighting HIV drug resistance in South Africa and has one of the most advanced treatment programmes for the management of resistance strains in the country. In addition, researchers at the University of the Free State are leading partners in the Southern African Treatment and Resistance Network (SATuRN; www.bioafrica.net/saturn), a research network that has trained over 2 000 medical officers in the treatment of drug resistance strains.

The Department of Medical Microbiology and Virology in the Medical School at the UFS has partnered with the provincial department of health, the Medical Research Council (MRC) and the Delegation of the European Union to South Africa to fund a dedicated DNA sequencer machine that will be used to generate HIV and TB drug-resistance results. This new machine will enable cutting-edge research to take place, using the data in the province and, importantly, support patients with resistance strains to have access to advanced genotypic testing techniques.

“HIV drug resistance is a very serious problem in South Africa, and the recent advances in DNA testing technology allow clinicians in the province to access drug resistance testing, which enables them to manage patients appropriately who fail treatment, and use the results to cost-effectively extend and improve patients’ lives,” says Dr Cloete van Vuuren, Specialist in Infectious Diseases at the UFS’s Faculty of Health.

Dr Dominique Goedhals, pathologist from the Department of Medical Microbiology and Virology at the UFS, adds: “We have been looking forward to expanding our work with the clinicians and researchers, using DNA sequencing to shed light on the causes and consequences of drug resistance in urban and rural settings in the province.”

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept